inmediQ GmbH at FIBO 2026: Insights into the Future of Cardiovascular Analysis

inmediQ GmbH was a featured exhibitor at FIBO 2026, presenting specialized solutions focused on the intersection of health, longevity, and advanced diagnostics. Located at stand 1D83, the company showcased technologies designed to turn pulse-wave signals into meaningful cardiovascular insights.

A Retrospective on the FIBO Showcase

The exhibition provided a platform for inmediQ GmbH to demonstrate its focus on precision health through innovative diagnostic tools. The presentation centered on the ability to translate pulse signals into actionable data, offering a new way to view the heart and vascular system through painless, non-invasive technology.

Advanced Cardiovascular Solutions

At the heart of the showcase were the company's core technologies:

• VasioCorder®: A high-resolution pulse-signal recorder designed for non-invasive use. The system features specially designed cuffs for six different measurement sites, including both upper arms, wrists, and ankles. By utilizing high-fidelity filtering technology, it autonomously captures pulse waves to provide a robust data foundation.
• VasioCore®: This system utilizes the data captured to build a patient-specific Cardiovascular Twin. This digital model enables the early detection of subclinical risk patterns by providing detailed insights into arterial elasticity, blood flow, and rhythm patterns.

These tools aim to support preventive strategies in longevity and performance-oriented healthcare by providing precise representations of vascular health.

Relevance for Health Professionals

The technologies presented at FIBO 2026 are particularly relevant for professionals interested in cardiovascular and metabolic diagnostics, biofeedback systems, and the application of Artificial Intelligence in health management. By focusing on the biological foundations of vitality, inmediQ GmbH demonstrated how advanced data can support the pursuit of healthy longevity.

For more information regarding the company and its technologies, visit https://inmediq.com/.